Glenveigh Pharmaceuticals, LLC

New Filing
CIK: 0001535853·Biotechnology·DELAWARE·Filed: Nov 29, 2011
Total Offering

$2,500,000

Amount Sold

$250,000

Investors

1

First Sale

Nov 14, 2011

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506
Entity Type
Limited Liability Company
Non-Accredited Investors
No

Related Persons

NameRole
Richard C Proctor, Jr.
Related Person
Charles David Adair
Related Person
Mark David Hackett
Related Person
Lizbeth Kennedy-Thomas
Related Person
Ken Couch
Related Person
William R Russell
Related Person
Richard Becherer
Related Person

Company

Glenveigh Pharmaceuticals, LLC

401 CHESTNUT STREET

CHATTANOOGA, TN, 37402

423-243-3460

SEC Filing

0001535853-11-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Glenveigh Pharmaceuticals, LLC Form D Filing — $2,500,000 | FilingFlow